Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.870
+0.070 (3.89%)
At close: Feb 21, 2025, 4:00 PM
2.080
+0.210 (11.23%)
After-hours: Feb 21, 2025, 7:59 PM EST
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $8.12 million as of February 21, 2025. Its market cap has increased by 326.51% in one year.
Market Cap
8.12M
Enterprise Value
1.34M
1-Year Change
326.51%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $8.12M, a decrease of -96.08%. That is a compound annual growth rate of -71.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 8.12M | -16.89% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |